A regulatory decision on the combination therapy is expected on February 8, 2025. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for ...
Zoloft is prescribed for various mood disorders, including depression, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). The dosage varies depending on the condition and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results